Navigation Links
The MedZilla Report: Febraury 2009 Employment Outlook for Biotech/Pharma/Health
Date:3/30/2009

After the flood of layoffs in health care in January, the industry seems to have taken a deep breath and a step back, getting back on track and creating 27,000 new jobs. Health care job cuts that were announced were mostly due to the overall economic difficulty facing the United States.

(Vocus) March 30, 2009 -- While it would be irresponsible to say the worst is past for health care, it does seem as though the industry took a deep breath and a step back in February, getting back on track after January's sweeping job cuts. About 27,000 new jobs were created in health care in February -- more than 8,000 more than were created in January -- which is more in line with 2008's average monthly job increases in the 30,000 range.


   
"For the most part, health care job cuts have come as a result of increased expenses due to the current economic situation," said Michele Hopps, director of marketing for MedZilla.com, the internet's leading site for health care, biotechnology, and pharmaceutical jobs. "The bigger hit this month unfortunately came from biotech and pharmaceuticals, which have both seen difficulties over the past 18 months." While most of those companies announced layoffs in conjunction with reorganizations, strategic shifts, and other cost-cutting measures, some, such as Trubion Pharmaceuticals, said they are eliminating positions "in the face of continuing uncertainty in the capital markets and the global economy." (Puget Sound Business Journal, February 25, 2009) Hopps said that these companies often see difficulty due to the need to specialize. "They develop drugs that might fail in clinical trials or the regulatory phase, and that's a lot of money gone toward something that won't show a return on the investment."
   
Though many health systems -- including an increasing number in Canada, primarily i
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health
2. The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health
3. PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013
4. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
5. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
6. Rabobank Releases Annual North American Food & Agribusiness Outlook
7. ViroPharma Provides 2008 Outlook
8. Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook
9. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
10. Gerresheimer: Record Year in 2007 and Positive Outlook for 2008
11. Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The MedZilla Report: Febraury 2009 Employment Outlook for Biotech/Pharma/Health
(Date:7/29/2015)... 30, 2015 Sanofi, un ... ses résultats pour le premier semestre 2015. Le ... résultats. Visionner l,interview vidéo et lire ... Au sommaire de l,interview :  ... de croissance - Diabète ...
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... Company,s Chief Financial Officer has resigned.  The Company has ... Officer who retired in December 2014, as full time ... permanent successor.     Andy Ashworth began ... ensure a smooth transition.  Andy was the Company,s CFO ...
(Date:7/29/2015)... DUBLIN , July 29, 2015 ... ) has announced the addition of the ... to their offering. The Global Biosimilars ... study of the rapidly growing biosimilars market. With ... industry striving to minimize costs, biosimilars are being ...
(Date:7/29/2015)... July 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... will be released on Thursday, August 13, 2015, before ... Pfenex management will host a conference call to discuss ... press release outlining the financial results and business update ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2
... on the road. Convinced that American companies are shipping too ... bus tour called Show Us the Jobs . , ... sites were among the 51 people who toured Wisconsin and ... Bush administration to promote a growing economy. , ,Make no ...
... any fan of the Wisconsin Film Festival , waiting ... is inevitably a frustrating part of the process. However, thanks ... festivals Web site, this year moviegoers will experience technological improvements ... Internet development firm IMS , the system is designed ...
... they knew about the work of the Wisconsin Legislature ... likely include God, guns and gays, alliterative shorthand for ... marriage. , ,While those issues commanded the heaviest headlines, ... the recently completed session of the Legislature. The real ...
Cached Biology Technology:Theres a surprising, and positive, side to the offshore jobs debate 2Theres a surprising, and positive, side to the offshore jobs debate 3Wisconsin Film Festival embraces new online ticket ordering system 2Wisconsin Film Festival embraces new online ticket ordering system 3Despite the three Gs, the Wisconsin Legislature had a productive session 2Despite the three Gs, the Wisconsin Legislature had a productive session 3
(Date:7/2/2015)... Research and Markets( ... "Natural Language Processing Market by Type (Rule-Based, ... & Image Recognition) - Worldwide Forecast to 2020" ... key vendors occupying the market are 3M, Apple, ... NetBase Solutions, SAS Institute Inc., Verint Systems among ...
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
(Date:6/26/2015)... , June 26, 2015 ATL Technology, LLC, a ... with specialties in single use solutions, headquartered in ... Inc. (a California corporation with locations ... San Jose, Costa Rica ). This ... Rica with ATL Technology,s existing facility in ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
... drug developed at the University of California, Davis to ... of human clinical trials to evaluate its efficacy. ... inhibitor, is "a first-in-class drug which may treat a ... Bruce Hammock, who with UC Berkeley cell biologist Sarjeet ...
... PITTSBURGH, March 26 Mutations in a gene may cause ... diseases such as chronic obstructive pulmonary disease (COPD) later in ... of Public Health and the German Research Center for Environmental ... measured expression levels of the gene and its variants in ...
... Ann Arbor, MI and Munich (Germany) March 26, ... solutions for the analysis of Next Generation Sequencing (NGS) ... Pathology (MCTP) at the University of Michigan installed a ... (GGA) at its labs in Ann Arbor, MI. GMS ...
Cached Biology News:UC Davis bench-to-bedside research: Promising treatment in clinical trials 2UC Davis bench-to-bedside research: Promising treatment in clinical trials 3UC Davis bench-to-bedside research: Promising treatment in clinical trials 4UC Davis bench-to-bedside research: Promising treatment in clinical trials 5Changes in gene may stunt lung development in children 2MCTP bought Genomatix NextGen Sequencing analysis stations 2
Rabbit polyclonal to SERHL ( Abpromise for all tested applications). entrezGeneID: 94009 SwissProtID: Q9H4I8...
... (Ser385) Immunogen: ... acid region encompassing the human, ... Accession Number: ... Quality Assurance: Routinely evaluated ...
Mouse monoclonal [YLI-90] to Ly49I (Biotin) ( Abpromise for all tested applications)....
TNR-R2...
Biology Products: